OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Beth Israel Medical Center, New York

North Shore University Hospital, Manhasset

Allegheny Pain Management, PC, Altoona

St. Mary Medical Center, Langhorne

St. Agnes Healthcare, Baltimore

MedSource Inc, Richmond

Cancer Outreach Associates, PC, Abingdon

The Center for Clinical Research, LLC, Winston-Salem

Southeastern Gynecologic Oncology, LLC, Atlanta

Florida Institute of Medical Research, Jacksonville

University of Florida Shands Cancer Center at Jacksonville, Jacksonville

Innovative Medical Research of South Florida, Miami Shores

Palm Beach Research, West Palm Beach

Florida Medical Clinic, PA, Zephyrhills

Clinical Pharmacology Services, Inc, Tampa

Gulf Coast Oncology Association, St. Petersburg

Center for Pain Management, Huntsville

Kentucky Cancer Clinic, Hazard

Huron Medical Center, Port Huron

Providence Cancer Institute, Southfield

North Shore Cancer Research Association, Skokie

HealthCare Research, LLC, St Louis

Bond Clinic, Inc, Rolla

Hematology and Oncology Specialists, New Orleans

Southwest Oncology Associates, Lafayette

Arkansas Cancer Institute, Pine Bluff

Hot Spring Pain Clinic, Hot Springs

Saint Joseph's Mercy Cancer Center, Hot Springs

PETC Research Group, Inc., Tulsa

UTHCT (ATTN: Clinical Research), Tyler

Mohamed Haq, Pasadena

Cancer Care Centers of South Texas, San Antonio

Great Basin Clinical Research, West Point

Hunstman Cancer Institute, Salt Lake City

Palliative Care and Pain Medicine, Salt Lake City

Outcomes Research International, Tucson

Arizona Clinical Research Center, Tucson

City of Hope National Medical Center, Duarte

The Cancer Prevention and Treatment Center, Soquel

Oncology Associates of Oregon, Eugene

Northwestern Connecticut Oncology & Hematology Associates, Torrington

Hematology Oncology Associates, Lake Worth

University of Wisconsin Medical School, Madison